A carregar...
Rituximab Administration within 6 months of T cell-Depleted Allogeneic SCT is Associated with Prolonged Life-threatening Cytopenias
The monoclonal anti CD20 antibody Rituximab (RTX) is increasingly used in allogeneic stem cell transplantation (SCT) to treat lymphoproliferative disorders and chronic graft-versus-host disease (GVHD). RTX administration can be complicated by delayed and prolonged neutropenia, but the mechanism is u...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2947610/ https://ncbi.nlm.nih.gov/pubmed/20580848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2010.05.004 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|